Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * # CSS, JS, Images Allow: /core/*.css$ Allow: /core/*.css? Allow: /core/*.js$ Allow: /core/*.js? Allow: /core/*.gif Allow: /core/*.jpg Allow: /core/*.jpeg Allow: /core/*.png Allow: /core/*.svg Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js? Allow: /profiles/*.gif Allow: /profiles/*.jpg Allow: /profiles/*.jpeg Allow: /profiles/*.png Allow: /profiles/*.svg Allow: /sites/default/files/**/*.pdf # Directories Disallow: |
Title | ICLUSIG® (ponatinib) Treatment in CML and Ph+ |
Description | WHAT’S THE NEXT STEP IN YOUR ICLUSIG is a tyrosine kinase inhibitor (TKI) medication for adults with CML or Ph+ ALL for whom previous TKI treatments have stopped working. Take the next step in your treatment with |
Keywords | N/A |
WebSite | iclusig.com |
Host IP | 52.85.47.125 |
Location | United States |
Site | Rank |
US$17,399,551
Last updated: 2023-05-15 14:42:47
iclusig.com has Semrush global rank of 608,309. iclusig.com has an estimated worth of US$ 17,399,551, based on its estimated Ads revenue. iclusig.com receives approximately 2,007,641 unique visitors each day. Its web server is located in United States, with IP address 52.85.47.125. According to SiteAdvisor, iclusig.com is safe to visit. |
Purchase/Sale Value | US$17,399,551 |
Daily Ads Revenue | US$16,062 |
Monthly Ads Revenue | US$481,834 |
Yearly Ads Revenue | US$5,782,005 |
Daily Unique Visitors | 133,843 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
iclusig.com. | A | 60 | IP: 52.85.47.125 |
iclusig.com. | A | 60 | IP: 52.85.47.11 |
iclusig.com. | A | 60 | IP: 52.85.47.62 |
iclusig.com. | A | 60 | IP: 52.85.47.23 |
iclusig.com. | NS | 86400 | NS Record: ns-387.awsdns-48.com. |
iclusig.com. | NS | 86400 | NS Record: ns-890.awsdns-47.net. |
iclusig.com. | NS | 86400 | NS Record: ns-1117.awsdns-11.org. |
iclusig.com. | NS | 86400 | NS Record: ns-1841.awsdns-38.co.uk. |
iclusig.com. | MX | 300 | MX Record: 10 inbound-smtp.us-east-1.amazonaws.com. |
iclusig.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.tkda.techspa.com -all |
skip to Main Content This site is intended for US patients only. Important Safety Information Medication Guide Prescribing Information Healthcare Professional Site Menu Close ICLUSIG in CML ICLUSIG Results in CML Understanding CML Side Effects ICLUSIG in Ph+ ALL ICLUSIG Results in Ph+ ALL Understanding Ph+ ALL Side Effects Taking ICLUSIG How to Take ICLUSIG Patient Support Here2Assist ® Resources WHAT’S THE NEXT STEP IN YOUR TREATMENT? When your CML or Ph+ ALL treatments are no longer working, ICLUSIG is a t yrosine kinase inhibitor (TKI) that may help you regain control. Learn about ICLUSIG Is ICLUSIG (ponatinib) right for you? ICLUSIG is a TKI medication that may treat adults with Chronic Myeloid Leukemia (CML) and Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL) for whom previous TKI treatments have stopped working. ICLUSIG may also be considered for adults with CML or Ph+ALL with the T315I mutation. ICLUSIG is not for use to treat people with newly diagnosed chronic |
HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Sun, 02 Jan 2022 09:03:27 GMT Content-Type: text/html Content-Length: 183 Connection: keep-alive Location: https://iclusig.com/ X-Cache: Redirect from cloudfront Via: 1.1 a875698e08bcdc7b13c04786dfe3a1ad.cloudfront.net (CloudFront) X-Amz-Cf-Pop: HEL50-C2 X-Amz-Cf-Id: PHxyXMcDIz18kVem1TAQwlDlSsgbLtwvtuBX5AFWr2C74-EB294GPw== HTTP/2 301 content-type: text/html content-length: 162 location: https://www.iclusig.com/ date: Sun, 02 Jan 2022 08:28:06 GMT x-cache: Hit from cloudfront via: 1.1 a481094379fbeeb96ddc8b0f96f0ce91.cloudfront.net (CloudFront) x-amz-cf-pop: HEL50-C2 x-amz-cf-id: qB6cPa_h9xlhWCPyXoj2RpegLXBM89qn299X9oCW8DzWXxSxVjofkw== age: 2122 HTTP/2 200 content-type: text/html; charset=utf-8 date: Sun, 02 Jan 2022 09:03:28 GMT set-cookie: INGRESSCOOKIE=1641114209.586.369.561385|a5632c5e5c14fdf19b31d6aa1d60a833; Path=/; Secure; HttpOnly x-cache: Miss from cloudfront via: 1.1 8250617d32eb5ab8f209b802320fccbb.cloudfront.net (CloudFront) x-amz-cf-pop: HEL50-C2 x-amz-cf-id: 4pIY2F8pnm3Q5S1bCo2oc62nv8PlZZxdvAAH09VhrVY6Ys0RXNDLHA== |
Domain Name: ICLUSIG.COM Registry Domain ID: 1672684786_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2020-03-16T04:20:28Z Creation Date: 2011-08-18T19:47:31Z Registry Expiry Date: 2022-08-18T19:47:31Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1117.AWSDNS-11.ORG Name Server: NS-1841.AWSDNS-38.CO.UK Name Server: NS-387.AWSDNS-48.COM Name Server: NS-890.AWSDNS-47.NET DNSSEC: unsigned >>> Last update of whois database: 2022-01-02T07:48:10Z <<< |